Posterior Reversible Encephalopathy Syndrome in a Normotensive Child after Allogeneic Hematopoietic Stem Cell Transplantation
Vol. 38 No. 4 (2019), Case Report
Vol. 38 No. 4 (2019)

Posterior Reversible Encephalopathy Syndrome in a Normotensive Child after Allogeneic Hematopoietic Stem Cell Transplantation

Case Report
Published 2019-12-04
Ömer Kartal
Gülhane Training and Research Hospital, Division of Pediatric Hematology and Oncology
Orhan Gürsel
Gülhane Training and Research Hospital, Division of Pediatric Hematology and Oncology
Bülent Ünay
Kemal Niyazi Arda
Gülhane Training and Research Hospital, Radiology Department
Erman Atas
Gülhane Training and Research Hospital, Division of Pediatric Oncology
PDF

Keywords

hematopoietic stem cell transplantation
cyclosporine
posterior reversible encephalopathy syndrome

How to Cite

Kartal, Ömer, Gürsel, O., Ünay, B., Arda, K. N., & Atas, E. (2019). Posterior Reversible Encephalopathy Syndrome in a Normotensive Child after Allogeneic Hematopoietic Stem Cell Transplantation. Puerto Rico Health Sciences Journal, 38(4). Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/1986
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Posterior reversible encephalopathy syndrome (PRES) is an uncommon clinicoradiological syndrome that is characterized by acute neurological symptoms such as headache, convulsion, visual disturbance, and altered consciousness. The characteristic magnetic resonance (MR) finding is vasogenic edema, predominantly in the subcortical areas of the posterior parietal and occipital lobes on T2‑weighted and fluid‑attenuated inversion recovery (FLAIR) sequences. Herein, we described a rare case of PRES induced by cyclosporine (CsA) after an allogeneic hematopoietic stem cell transplantation (HSCT) from a sibling donor.
PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).